🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
The purpose of this study is to evaluate the efficacy and safety of subling...
Status
Completed
Location
AFIP
Start Date
2013-02-18
Trial ID
NCT01896336
Treatments Being Tested
The main objective is to co-design and assess the practicality of group-bas...
Status
Completed
Location
Nanjing Maternity and Child Health Care Hospital
Start Date
2022-08-21
Trial ID
NCT05242809
Treatments Being Tested
To evaluate the clinical utility associated with the integration of Cxbladd...
Status
Completed
Location
Institute of Urology, USC Norris Comprehensive Cancer Center
Start Date
2019-09-11
Trial ID
NCT03988309
Treatments Being Tested
This is a multi-center, randomized, double blind, placebo-controlled phase ...
Status
Completed
Location
Beijing Chao-Yang Hospital, Capital Medical University
Start Date
2021-02-24
Trial ID
NCT04805411
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
Prospective, double-blind, randomized assessment of the efficacy, safety an...
Status
Completed
Location
Research Site 1
Start Date
2017-03-29
Trial ID
NCT03027609
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999